ProjectCC-10004-PSOR-020
Basic data
Title:
CC-10004-PSOR-020
Duration:
01/10/2019 to 31/12/2020
Abstract / short description:
Eine multizentrische, randomisierte, d0ppelblinde, placebokontrollierte Phase-IV-Studie zur Auswirkung von Apremilast (CC-10004) auf die Lebensqualität, Wirksamkeit und Sicherheit bei Patienten mit Plaque-Psoriasis mit eingeschränkter Lebensqualität.
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
München, Bayern, Germany